Ritonavir, once a protease inhibitor used to treat HIV, was later found to effectively reduce the level of IL-18 in mouse pancreatic cancer by suppressing caspase-1 activation (Kast, 2008) with the potential application in stroke. The gene discussed is IL18; the disease is stroke disorder.